
    
      Objective of this pivotal study was to assess the bioequivalence between Test Product:
      Lisinopril Tablets 40 mg of Ipca Laboratories Limited, India and the corresponding Reference
      Product: ZestrilÂ® (Lisinopril) 40 mg Tablets of AstraZeneca Pharmaceuticals LP USA, under
      fasting condition in normal, healthy, adult, male and female human subjects in a randomized
      crossover study.

      The study was conducted with 40 healthy adult subjects. In each study period, a single 40 mg
      dose of either test or reference was administered to the subjects as per the randomization
      schedule in each study period with about 240 mL of water at ambient temperature in sitting
      position.

      The duration of the clinical phase was approximately 19 days including washout period of 15
      days between administrations of study drug in each study period.
    
  